The side effects of anti-tuberculosis treatment: a retrospective analysis Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002
Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR) Source: Annual Congress 2009 - Tuberculosis control Year: 2009
Patterns of drug resistance in pulmonary tuberculosis: results of an open prospective study in Tanta, Egypt Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001
First countrywide observational study of acquired drug resistance among TB cases in Ukraine Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR – TB in Iran Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
Second-line tuberculosis drug resistance study from a referal center of Turkey Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
A retrospective analysis of quinolone prescriptions for tuberculosis in two North Birmingham hospitals Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
A prospective study of multiple drug-resistant tuberculosis in Plovdiv region, Bulgaria, 1989–2004 Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019
Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India. Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Cohort analysis in country with high level of multidrug resistant TB: how and when? Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Genotypic and phenotypic drug resistance of M.tuberculosis in patients registered in Moscow, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Comparative analysis and epidemiological aspects of spreading tuberculosis strains in Kharkiv region, Eastern Ukraine Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania Source: Annual Congress 2007 - Tuberculosis control Year: 2007
Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study. Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009